Balyasny Asset Management
RMD icon

Balyasny Asset Management’s ResMed RMD Stock Holding History

Balyasny Asset Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,100
Closed -$1.67M – 3486
2025
Q3 		$1.67M Sell
6,100
-1,600
-21% -$437K ﹤0.01% 1888
2025
Q2 		$1.99M Sell
7,700
-700
-8% -$167K ﹤0.01% 1733
2025
Q1 		$1.88M Sell
8,400
-129,200
-94% -$30.2M ﹤0.01% 1733
2024
Q4 		$31.5M Buy
137,600
+35,400
+35% +$8.52M 0.05% 478
2024
Q3 		$24.9M Sell
102,200
-17,800
-15% -$3.98M 0.04% 553
2024
Q2 		$23M Buy
120,000
+117,900
+5,614% +$23.9M 0.04% 558
2024
Q1 		$416K Buy
+2,100
New +$385K ﹤0.01% 2121
2013
Q4 		– Sell
-35,000
Closed -$4.15M – 609
2013
Q3 		$4.15M Sell
35,000
-311,500
-90% -$15.1M 0.06% 375
2013
Q2 		$15.6M Buy
+346,500
New +$16.4M 0.26% 94

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Balyasny Asset Management's RMD Position: Q2 2026 in Review

Balyasny Asset Management increased its ResMed (RMD) stake by 50% in Q2 2026, buying an estimated $227K and bringing the position to 3,291 shares worth $641K. The position accounts for ﹤0.01% of the portfolio, ranked #2419.

Balyasny Asset Management first reported a position in RMD in Q2 2015 and has held it in 25 quarters since. The position peaked at $65.8M in Q4 2021. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Balyasny Asset Management held 3,291 shares of ResMed worth $641K as of Q2 2026.
  • Balyasny Asset Management bought 1,094 ResMed shares in Q2 2026, an estimated $227K.
  • ResMed made up ﹤0.01% of Balyasny Asset Management's portfolio in Q2 2026, its #2419 holding.
  • Balyasny Asset Management first reported a position in ResMed in Q2 2015 and has held it in 25 quarters since.
  • Balyasny Asset Management's ResMed position peaked at $65.8M in Q4 2021.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.